FTC stated that the 'Big 3' PBM organisations collectively generated over £5.94 billion ($7.3 billion) in revenue from 2017 to 2022.

Evercore ISI has updated its outlook on CVS Health (NYSE:CVS) shares, raising the price target from $60.00 to $65.00 while ...

In a report released today, Stephen Baxter from Wells Fargo maintained a Buy rating on UnitedHealth (UNH – Research Report), with a price ...

Shares of Cigna Group slipped 6.70% to $282.98 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 0.53% to 6,071.17 and the Dow ...

Piper Sandler analyst Jessica Tassan maintained a Buy rating on UnitedHealth (UNH – Research Report) today and set a price target of $600.00.

The lawsuit claims that three major healthcare companies were pushing up the price of insulin by 1,200 percent.

(Bloomberg) -- Units of CVS Health Corp., Cigna Group and UnitedHealth Group Inc. charged significantly more than the national average acquisition cost for dozens of specialty generic drugs ...

Investing.com -- Shares of CVS Health Corp (NYSE:CVS), Cigna (NYSE:CI) Group, and UnitedHealth Group Inc (NYSE:UNH) were down around 1% after the Federal Trade Commission (FTC) accused their ...

UnitedHealth, the biggest insurance company in America, is receiving backlash after an FTC report revealed that it was ...

The FTC report showed that from 2017 to 2022, the three PBMs—UnitedHealth Group's Optum, CVS Health's CVS Caremark and Cigna's Express Scripts—marked up prices at their pharmacies by hundreds ...

Shares of CVS Health, UnitedHealth Group and Cigna, owners of the leading pharmacy-benefit managers, all declined, compounding losses from late last year. Neumora Therapeutics slid by more than ...